[{"data":1,"prerenderedAt":26},["ShallowReactive",2],{"$fHIwuK0a0p8seXvNlGkETuRog1Nw9Q-di_AOmzDI3e0A":3},{"card":4,"examId":6,"chapterTitle":23,"prev":24,"next":25},{"id":5,"examId":6,"prompt":7,"answer":8,"choices":9,"questionType":14,"explanation":15,"explanationDetail":16,"mistakeHint":16,"lectureRef":16,"storyRef":16,"chapterSlug":17,"sectionCode":18,"sectionTitle":19,"clusterSlug":20,"term":21,"sequenceOrder":16,"regionWeight":16,"revisionMark":16,"isActive":22},"ch1-013","touhan","PL法（製造物責任法）が一般用医薬品に適用される場合として正しいものはどれか。",3,[10,11,12,13],"用法を守らずに副作用が出た場合","使用期限内に副作用が生じた場合","添付文書の記載が不親切な場合","販売した製品に明らかな欠陥があった場合","four","一般用医薬品であっても、販売された製品自体に「明らかな欠陥」があった場合は、PL法の対象となる可能性があります。",null,"chapter-1","1-I-1","医薬品の本質","iyakuhin-honshitsu","製造物責任法（PL法）",true,"第1章 医薬品に共通する特性と基本的な知識","ch1-012","ch1-014",1784619073783]